12-101746034-A-AAAC
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_024312.5(GNPTAB):c.*1127_*1129dupGTT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0113 in 152,202 control chromosomes in the GnomAD database, including 41 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.011 ( 41 hom., cov: 33)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
GNPTAB
NM_024312.5 3_prime_UTR
NM_024312.5 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.39
Publications
0 publications found
Genes affected
GNPTAB (HGNC:29670): (N-acetylglucosamine-1-phosphate transferase subunits alpha and beta) This gene encodes two of three subunit types of the membrane-bound enzyme N-acetylglucosamine-1-phosphotransferase, a heterohexameric complex composed of two alpha, two beta, and two gamma subunits. The encoded protein is proteolytically cleaved at the Lys928-Asp929 bond to yield mature alpha and beta polypeptides while the gamma subunits are the product of a distinct gene (GeneID 84572). In the Golgi apparatus, the heterohexameric complex catalyzes the first step in the synthesis of mannose 6-phosphate recognition markers on certain oligosaccharides of newly synthesized lysosomal enzymes. These recognition markers are essential for appropriate trafficking of lysosomal enzymes. Mutations in this gene have been associated with both mucolipidosis II and mucolipidosis IIIA.[provided by RefSeq, May 2010]
GNPTAB Gene-Disease associations (from GenCC):
- GNPTAB-mucolipidosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- mucolipidosisInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
- mucolipidosis type IIInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, Genomics England PanelApp
- mucolipidosis type III, alpha/betaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, G2P, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 12-101746034-A-AAAC is Benign according to our data. Variant chr12-101746034-A-AAAC is described in ClinVar as [Likely_benign]. Clinvar id is 306774.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0113 (1721/152202) while in subpopulation AFR AF = 0.0386 (1601/41498). AF 95% confidence interval is 0.037. There are 41 homozygotes in GnomAd4. There are 819 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 41 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0112 AC: 1708AN: 152084Hom.: 40 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
1708
AN:
152084
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 236Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 184
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
236
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
184
African (AFR)
AF:
AC:
0
AN:
2
American (AMR)
AF:
AC:
0
AN:
2
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
4
East Asian (EAS)
AF:
AC:
0
AN:
2
South Asian (SAS)
AF:
AC:
0
AN:
2
European-Finnish (FIN)
AF:
AC:
0
AN:
4
Middle Eastern (MID)
AF:
AC:
0
AN:
2
European-Non Finnish (NFE)
AF:
AC:
0
AN:
208
Other (OTH)
AF:
AC:
0
AN:
10
GnomAD4 genome AF: 0.0113 AC: 1721AN: 152202Hom.: 41 Cov.: 33 AF XY: 0.0110 AC XY: 819AN XY: 74436 show subpopulations
GnomAD4 genome
AF:
AC:
1721
AN:
152202
Hom.:
Cov.:
33
AF XY:
AC XY:
819
AN XY:
74436
show subpopulations
African (AFR)
AF:
AC:
1601
AN:
41498
American (AMR)
AF:
AC:
73
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5190
South Asian (SAS)
AF:
AC:
2
AN:
4812
European-Finnish (FIN)
AF:
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
22
AN:
68018
Other (OTH)
AF:
AC:
23
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
74
148
222
296
370
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Pseudo-Hurler polydystrophy Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Mucolipidosis type II Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.